Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06421103
Other study ID # 23BO01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 2024
Est. completion date August 2028

Study information

Verified date May 2024
Source Great Ormond Street Hospital for Children NHS Foundation Trust
Contact Stefano Giuliani
Phone 02074059200
Email stefano.giuliani@gosh.nhs.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this cohort study is to identify the lowest dose of Indocyanine Green (ICG) that achieves satisfactory intra-operative fluorescence for the assessment of gastrointestinal or genitourinary tract perfusion in children.


Description:

Indocyanine Green (ICG) fluorescence-guided surgery (FGS) can be used to assess gastrointestinal and genitourinary tract perfusion intra-operatively. In adults, the use of ICG has been shown to improve surgical outcomes. ICG is safely used intra-operatively in children, but there is a lack of evidence regarding the lowest clinically useful dose of ICG. This is a single centre open-label dose escalation study that aims to: 1. identify the minimal clinically useful dose of ICG for intra-operative perfusion assessment in children (0 - 18 years old) 2. assess the safety profile of intra-operative ICG in children 3. characterise the intra-operative fluorescence of ICG in children


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date August 2028
Est. primary completion date August 2028
Accepts healthy volunteers No
Gender All
Age group N/A to 18 Years
Eligibility Inclusion Criteria: - Children aged =18 years of age - Elective surgery including gastrointestinal or genitourinary tract perfusion assessment Exclusion Criteria: - Renal and liver dysfunction - Active infection - Coagulopathy - Complex congenital heart defect - Previous documented allergy to ICG injection or other iodinated contrast agents - Patients suffering from hyperthyroidism or autonomic thyroid adenomas - Premature infants or neonates in whom exchange transfusion is indicated, due to the hyperbilirubinaemia risk - Concurrent use of sodium bisulphite-containing preparations, such as certain heparin preparations

Study Design


Intervention

Drug:
Indocyanine Green (ICG)
Cohorts will receive 0.01 mg/kg, 0.02 mg/kg, 0.04mg/kg, 0.06 mg/kg, or 0.08 mg/kg intra-venous ICG at surgery. Patients will be consecutively allocated to different doses as per protocol.

Locations

Country Name City State
United Kingdom Great Ormond Street Hospital for Children London

Sponsors (1)

Lead Sponsor Collaborator
Great Ormond Street Hospital for Children NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Minimum clinically useful dose of ICG in children Identify the minimum dose of ICG at which intra-operative perfusion assessment is achieveable. Assessment will be based objectively on mean fluorescence intensity and the fluorescence-time curve, and subjectively by the operating surgeon. 60 minutes (intra-operative)
Primary Number of adverse drug events at each dose level An appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment, or alteration of the dosage regimen, or withdrawal of the product 30 days
Secondary Surgical complications Intra-operative and early postoperative complications and mortality (defined as an event observed within 30 days after surgery). Frequency and details. 30 days
Secondary Post-operative morbidity Further procedures, complications and mortality occuring within the 30 - 90 day time period (late post-operative complications). Frequency and details. 90 days
Secondary Length of stay Time in hospital post-procedure 90 days
See also
  Status Clinical Trial Phase
Recruiting NCT06158217 - Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer
Completed NCT06220357 - Diluted Indocyanine Green Angiography: a Novel Approach to Free Flap Perfusion Evaluation in Reconstructive Microsurgery N/A
Completed NCT02612883 - Flux Measurement and Outcome in Major Abdominal Surgery
Recruiting NCT06034834 - Near-Infrared Imaging for Perfusion Assessment of Traumatic Soft Tissue and Skeletal Injuries N/A
Recruiting NCT06222645 - PPG vs. ICG in Gastrointestinal Resections N/A
Completed NCT03644420 - Evaluation of Patients With Knee Osteoarthritis Receiving a Prosthesis
Completed NCT03121443 - Patient Positions and Perfusion Index N/A
Recruiting NCT02449525 - Extracorporeal Perfusion of Microvascular Free Flaps N/A
Recruiting NCT05893407 - Brain PERfusion Evaluation by Contrast-Enhanced UltraSound
Completed NCT01168557 - Stress Echo and Electric Impedance Tomography (EIT) Pilot Study N/A
Terminated NCT05243914 - Heart Transplantation Utilizing NRP DCD
Recruiting NCT01756014 - Brain Function and Perfusion in Patients With Heart Failure N/A
Recruiting NCT04226781 - ICG vs. HSI in Gastrointestinal Resections N/A
Completed NCT04233177 - The Effect of Trendelenburg Position on CCA Blood Flow
Not yet recruiting NCT03046628 - Evaluation of Lower Extremity Tissue Perfusion With Polarized Laser Light N/A
Completed NCT03048162 - The Effects of Intravenous Fluids on Perfusion Index and Pleth Variability Index N/A
Completed NCT02646150 - Clinical Use of Magnetic Resonance Perfusion Imaging to Qualitatively Assess Adequate Distal Perfusion After Endovascular Revascularization in Critical Limb Ischemia
Completed NCT03180060 - Meta-Analysis of Stress Myocardial Perfusion Imaging N/A
Completed NCT03151369 - Visual Pain Score and Perfusion Index in Postoperative Patients N/A